These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12973924)

  • 1. Mechanism of three inhibitors of TACE in blocking the converting of pro-TNF alpha into sTNF alpha.
    Wang Z; Wang Y; Zhu K; Guo L; Yang Y
    J Huazhong Univ Sci Technolog Med Sci; 2003; 23(2):116-20. PubMed ID: 12973924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of reduqing on HL-60 cells in secreting tumor necrosis factor alpha production and on TNF alpha converting enzyme mRNA expression].
    Wang KF; Li MZ; Yang YZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Apr; 21(4):283-5. PubMed ID: 12577359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the increase of secretion of sTNF alpha induced by lipopolysaccharides and the enhanced expression of TACE mRNA in HL-60 cells and adhesive cells from human spleen.
    Ding T; Li L; Zhu K; Huang W; Yang Y
    J Tongji Med Univ; 2001; 21(4):265-8, 279. PubMed ID: 12539543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the effects of LPS on the TACE gene expression and its function.
    Li L; Yang Y; Wang Z; Gong F
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(1):5-8. PubMed ID: 12658769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.
    Zhang Y; Xu J; Levin J; Hegen M; Li G; Robertshaw H; Brennan F; Cummons T; Clarke D; Vansell N; Nickerson-Nutter C; Barone D; Mohler K; Black R; Skotnicki J; Gibbons J; Feldmann M; Frost P; Larsen G; Lin LL
    J Pharmacol Exp Ther; 2004 Apr; 309(1):348-55. PubMed ID: 14718605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour necrosis factor-alpha converting enzyme (TACE) activity in human colonic epithelial cells.
    Kirkegaard T; Pedersen G; Saermark T; Brynskov J
    Clin Exp Immunol; 2004 Jan; 135(1):146-53. PubMed ID: 14678276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of tumor necrosis factor-alpha--converting enzyme and tumor necrosis factor-alpha in human myocarditis.
    Satoh M; Nakamura M; Satoh H; Saitoh H; Segawa I; Hiramori K
    J Am Coll Cardiol; 2000 Oct; 36(4):1288-94. PubMed ID: 11028485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrocyclic θ-defensins suppress tumor necrosis factor-α (TNF-α) shedding by inhibition of TNF-α-converting enzyme.
    Schaal JB; Maretzky T; Tran DQ; Tran PA; Tongaonkar P; Blobel CP; Ouellette AJ; Selsted ME
    J Biol Chem; 2018 Feb; 293(8):2725-2734. PubMed ID: 29317500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human dilated cardiomyopathy.
    Satoh M; Nakamura M; Saitoh H; Satoh H; Maesawa C; Segawa I; Tashiro A; Hiramori K
    Circulation; 1999 Jun; 99(25):3260-5. PubMed ID: 10385500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased mRNA expression of tumour necrosis factor-alpha and its converting enzyme in circulating leucocytes of patients with acute myocardial infarction.
    Akatsu T; Nakamura M; Satoh M; Hiramori K
    Clin Sci (Lond); 2003 Jul; 105(1):39-44. PubMed ID: 12605594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and localization of tumour necrosis factor-alpha and its converting enzyme in human abdominal aortic aneurysm.
    Satoh H; Nakamura M; Satoh M; Nakajima T; Izumoto H; Maesawa C; Kawazoe K; Masuda T; Hiramori K
    Clin Sci (Lond); 2004 Mar; 106(3):301-6. PubMed ID: 14580234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).
    Rabinowitz MH; Andrews RC; Becherer JD; Bickett DM; Bubacz DG; Conway JG; Cowan DJ; Gaul M; Glennon K; Lambert MH; Leesnitzer MA; McDougald DL; Moss ML; Musso DL; Rizzolio MC
    J Med Chem; 2001 Nov; 44(24):4252-67. PubMed ID: 11708926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: a dominant negative form of TNF-alpha converting enzyme inhibits proTNF and TNFRII secretion.
    Solomon KA; Pesti N; Wu G; Newton RC
    J Immunol; 1999 Oct; 163(8):4105-8. PubMed ID: 10510344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of tumor necrosis factor-alpha converting enzyme and tumor necrosis factor-alpha in peripheral blood mononuclear cells in patients with advanced congestive heart failure.
    Satoh M; Iwasaka J; Nakamura M; Akatsu T; Shimoda Y; Hiramori K
    Eur J Heart Fail; 2004 Dec; 6(7):869-75. PubMed ID: 15556048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF blocker drugs modulate human TNF-α-converting enzyme pro-domain shedding induced by autoantibodies.
    Sisto M; Lisi S; Lofrumento DD; Caprio S; Mitolo V; D'Amore M
    Immunobiology; 2010 Nov; 215(11):874-83. PubMed ID: 20061048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ localization of TNFalpha/beta, TACE and TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue.
    Ermert M; Pantazis C; Duncker HR; Grimminger F; Seeger W; Ermert L
    Cytokine; 2003 May; 22(3-4):89-100. PubMed ID: 12849708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of (2R, 3S)-2-([[4-(2-butynyloxy)phenyl]sulfonyl]amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-alpha converting enzyme.
    Zhang Y; Hegen M; Xu J; Keith JC; Jin G; Du X; Cummons T; Sheppard BJ; Sun L; Zhu Y; Rao VR; Wang Q; Xu W; Cowling R; Nickerson-Nutter CL; Gibbons J; Skotnicki J; Lin LL; Levin J
    Int Immunopharmacol; 2004 Dec; 4(14):1845-57. PubMed ID: 15531300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of tumor necrosis factor-alpha in cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1alpha.
    Imaizumi T; Itaya H; Fujita K; Kudoh D; Kudoh S; Mori K; Fujimoto K; Matsumiya T; Yoshida H; Satoh K
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):410-5. PubMed ID: 10669637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlike for human monocytes after LPS activation, release of TNF-α by THP-1 cells is produced by a TACE catalytically different from constitutive TACE.
    Moreira-Tabaka H; Peluso J; Vonesch JL; Hentsch D; Kessler P; Reimund JM; Dumont S; Muller CD
    PLoS One; 2012; 7(3):e34184. PubMed ID: 22479555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of TNF-alpha convertase (TACE/ADAM17) after oxygen-glucose deprivation in rat forebrain slices.
    Hurtado O; Cárdenas A; Lizasoain I; Boscá L; Leza JC; Lorenzo P; Moro MA
    Neuropharmacology; 2001 Jun; 40(8):1094-102. PubMed ID: 11406201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.